MRI‐based radiomics analysis for predicting the EGFR mutation based on thoracic spinal metastases in lung adenocarcinoma patients. Issue 9 (6th August 2021)

• Record Type: Journal Article
• Authors: Ren, Meihong; Yang, Huazhe; Lai, Qingyuan; Shi, Dabao; Liu, Guanyu; Shuang, Xue; Su, Juan; Xie, Liping; Dong, Yue; Jiang, Xiran
• Is Part Of: Medical physics. Volume 48:Issue 9(2021)
• Page Start: 5142
• Page End: 5151
• Publication Date: 2021-08-06
• Subjects: EGFR -- MRI -- thoracic spinal metastases; Medical physics -- Periodicals; Medical physics; Geneeskunde; Natuurkunde; Toepassingen; Biophysics; Periodicals; Periodicals; Electronic journals; 610.153
• DOI: 10.1002/mp.15137
• Languages: English
• ISSNs: 0094-2405

Abstract

Abstract: Purpose: This study aims to develop and evaluate multi‐parametric MRI‐based radiomics for preoperative identification of epidermal growth factor receptor (EGFR) mutation, which is important in treatment planning for patients with thoracic spinal metastases from primary lung adenocarcinoma. Methods: A total of 110 patients were enrolled between January 2016 and March 2019 as a primary cohort. A time‐independent validation cohort was conducted containing 52 patients consecutively enrolled from July 2019 to April 2021. The patients were pathologically diagnosed with thoracic spinal metastases from primary lung adenocarcinoma; all underwent T1‐weighted (T1W), T2‐weighted (T2W), and T2‐weighted fat‐suppressed (T2FS) MRI scans of the thoracic spinal. Handcrafted and deep learning‐based features were extracted and selected from each MRI modality, and used to build the radiomics signature. Various machine learning classifiers were developed and compared. A clinical‐radiomics nomogram integrating the combined rad signature and the most important clinical factor was constructed with receiver operating characteristic (ROC), calibration, and decision curves analysis (DCA) to evaluate the prediction performance. Results: The combined radiomics signature derived from the joint of three modalities can effectively classify EGFR mutation and EGFR wild‐type patients, with an area under the ROC curve (AUC) of 0.886 (95% confidence interval [CI]: 0.826–0.947, SEN =0.935, SPE =0.688) in the training group and 0.803 (95% CI: 0.682–0.924, SEN = 0.700, SPE = 0.818) in the time‐independent validation group. The nomogram incorporating the combined radiomics signature and smoking status achieved the best prediction performance in the training (AUC = 0.888, 95% CI: 0.849–0.958, SEN = 0.839, SPE = 0.792) and time‐independent validation (AUC = 0.821, 95% CI: 0.692–0.929, SEN = 0.667, SPE = 0.909) cohorts. The DCA confirmed potential clinical usefulness of our nomogram. Conclusion: Our study demonstrated the potential of multi‐parametric MRI‐based radiomics on preoperatively predicting the EGFR mutation. The proposed nomogram model can be considered as a new biomarker to guide the selection of individual treatment strategies for patients with thoracic spinal metastases from primary lung adenocarcinoma.